Milestone Scientific Inc. (MLSS)

NYSEAMERICAN: MLSS · Real-Time Price · USD
0.4307
-0.0504 (-10.48%)
Aug 1, 2025, 4:00 PM - Market closed
-10.48%
Market Cap33.80M
Revenue (ttm)8.61M
Net Income (ttm)-5.27M
Shares Out 78.48M
EPS (ttm)-0.07
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume302,947
Open0.4900
Previous Close0.4811
Day's Range0.3753 - 0.5000
52-Week Range0.3753 - 1.3930
Beta0.80
AnalystsBuy
Price Target1.25 (+190.23%)
Earnings DateAug 13, 2025

About MLSS

Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments. The company provides the Wand, a single use disposable handpiece device for dental procedures that require local anesthetic under the CompuDent and STA Single Tooth Anesthesia System names. It also offers CompuFlo, a computer-controlled drug delivery sys... [Read more]

Sector Healthcare
IPO Date Nov 3, 1995
Employees 17
Stock Exchange NYSEAMERICAN
Ticker Symbol MLSS
Full Company Profile

Financial Performance

In 2024, Milestone Scientific's revenue was $8.63 million, a decrease of -12.19% compared to the previous year's $9.83 million. Losses were -$4.71 million, -31.97% less than in 2023.

Financial Statements

Analyst Summary

According to one analyst, the rating for MLSS stock is "Buy" and the 12-month stock price target is $1.25.

Price Target
$1.25
(190.23% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Milestone Scientific Appoints Eric C. Hines as Chief Executive Officer

Seasoned executive with proven track record driving growth and building customer focused teams to lead Milestone's next phase of commercial execution Seasoned executive with proven track record drivin...

1 day ago - GlobeNewsWire

Milestone Scientific Commences Sales of CompuFlo® Epidural System at The Painless Center in Tenafly, New Jersey

ROSELAND, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, to...

16 days ago - GlobeNewsWire

Milestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of Directors

Brings Proven Commercial Leadership, Reimbursement Expertise, and Global Market Insight to Support Next Phase of Growth Across Medical and Dental Segments Brings Proven Commercial Leadership, Reimburs...

2 months ago - GlobeNewsWire

Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2025

ROSELAND, N.J., May 15, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, tod...

2 months ago - GlobeNewsWire

Milestone Scientific Expands CompuFlo® Epidural System Footprint with InfiniSurg, LLC in New Jersey

Dr. Roman Kosiborod, DO to Utilize CompuFlo® for Enhanced Precision in Pain Management Procedures Dr. Roman Kosiborod, DO to Utilize CompuFlo® for Enhanced Precision in Pain Management Procedures

4 months ago - GlobeNewsWire

Milestone Scientific Expands Adoption of CompuFlo® Epidural System with Commercial Rollout at Pain Doctors Medical LLC

Dr. Ilana Etelzon Integrates CompuFlo® Epidural System into Practice Following Positive Clinical Experience Dr. Ilana Etelzon Integrates CompuFlo® Epidural System into Practice Following Positive Clin...

6 months ago - GlobeNewsWire

Milestone Scientific Announces Commercial Rollout of CompuFlo® Epidural System at Advanced Spine and Pain Management Following Successful Pilot with Dr. Varinder Dhillon

Reports Expanding Adoption of CompuFlo® Epidural System Following Previously Announced Medicare Price Assignment Reports Expanding Adoption of CompuFlo® Epidural System Following Previously Announced ...

6 months ago - GlobeNewsWire

Milestone Scientific to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference on December 11th, 2024

ROSELAND, N.J., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, to...

8 months ago - GlobeNewsWire

Milestone Scientific Secures Federal Supply Schedule (FSS) Approval on Contract for CompuFlo® Epidural System

Contract Unlocks Significant Market Opportunities Across Federal Healthcare Systems Contract Unlocks Significant Market Opportunities Across Federal Healthcare Systems

8 months ago - GlobeNewsWire

Milestone Scientific Inc. (MLSS) Q3 2024 Earnings Call Transcript

Milestone Scientific Inc. (NYSE:MLSS) Q3 2024 Earnings Call Transcript November 15, 2024 8:30 AM ET Company Participants David Waldman - Crescendo Communications, Investor Relations Arjan Haverhals -...

9 months ago - Seeking Alpha

Milestone Scientific Achieves 22% Increase in Revenue for the Third Quarter of 2024

Reports 57% increase in international dental sales for the third quarter of 2024 Advances commercial rollout of CompuFlo® Epidural System across additional pain management clinics following Medicare p...

9 months ago - GlobeNewsWire

Milestone Scientific Announces CEO Transition, with Chairman Neal Goldman Serving as Interim CEO

ROSELAND, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, to...

9 months ago - GlobeNewsWire

Milestone Scientific Schedules Third Quarter 2024 Financial Results and Business Update Conference Call

ROSELAND, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, to...

9 months ago - GlobeNewsWire

Milestone Scientific Expands Commercial Rollout of the CompuFlo® Epidural System with Esteemed Pain Management Physician Dr. Elbaz at Hudson Specialty Care

Recent Medicare Price Assignment Driving Increased Access to CompuFlo Milestone Scientific to Attend New York and New Jersey Pain Medicine Congress 2024 ROSELAND, N.J., Nov. 01, 2024 (GLOBE NEWSWIRE) ...

9 months ago - GlobeNewsWire

Milestone Scientific Announces Commercial Rollout of CompuFlo® Epidural System at iHeal Pain Center Following Medicare Price Assignment

Reports Robust Pipeline of Clinics in Trials Across Multiple States through Partnership with Axial Biologics Reports Robust Pipeline of Clinics in Trials Across Multiple States through Partnership wit...

10 months ago - GlobeNewsWire

Milestone Scientific Inc. (MLSS) Q2 2024 Earnings Call Transcript

Milestone Scientific Inc. (NYSE:MLSS) Q2 2024 Earnings Conference Call August 15, 2024 8:30 AM ET Company Participants David Waldman - Investor Relations, Crescendo Communications Arjan Haverhals - C...

1 year ago - Seeking Alpha

Milestone Scientific Provides Business Update and Reports Financial Results for the Second Quarter of 2024

Secured Medicare price assignment for the CompuFlo® Epidural System in multiple U.S. states Gross margin for the second quarter of 2024 increased to 76.1% from 65.0% for the same period last year driv...

1 year ago - GlobeNewsWire

Milestone Scientific Schedules Second Quarter 2024 Financial Results and Business Update Conference Call

ROSELAND, N.J., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, to...

1 year ago - GlobeNewsWire

Milestone Scientific Announces Strategic Partnership with Axial Biologics to Distribute CompuFlo® in New Jersey, Texas, and Florida

ROSELAND, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, to...

1 year ago - GlobeNewsWire

Milestone Scientific Secures Key Patent Approvals in the U.S. and Europe

ROSELAND, N.J., July 30, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, to...

1 year ago - GlobeNewsWire

Milestone Scientific Announces Medicare Price Assignment for the CompuFlo® Epidural System in Texas, Pennsylvania, New Jersey, Maryland, Colorado, Oklahoma, Louisiana, Arkansas, Mississippi, New Mexico, District of Columbia, and Delaware

ROSELAND, N.J., July 23, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, to...

1 year ago - GlobeNewsWire

Milestone Scientific Receives Regulatory Approval to Market CompuFlo® Epidural System in Brazil

Brazil is the 9th largest economy in the world with more than  21 million people suffering from chronic back pain

1 year ago - GlobeNewsWire

Milestone Scientific Inc. (MLSS) Q1 2024 Earnings Call Transcript

Milestone Scientific Inc. (MLSS) Q1 2024 Earnings Call Transcript

1 year ago - Seeking Alpha

Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2024

Sales through new online portal increase 31% over the same period last year Gross margin for the first quarter of 2024 increases to 74.5% from 72.7% for the same period last year Reports steady progre...

1 year ago - GlobeNewsWire

Milestone Scientific Schedules First Quarter 2024 Financial Results and Business Update Conference Call

ROSELAND, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, tod...

1 year ago - GlobeNewsWire